abstract |
The invention belongs to the field of biomedicine, and particularly relates to the application of alternatively spliced transcripts in judging the sensitivity of cell cycle drugs. Therefore, the present invention provides the application of the reagent for detecting the expression level of ENST00000547281 in the preparation of a product for judging the drug sensitivity of patients to Palbociclib and Ribociclib. |